The Latest Breaking News from Moderna

A whale with a lot of money to spend has taken a noticeably bearish stance on Moderna. Looking at options history for Moderna (NASDAQ:MRNA) we detected 53 strange trades.

Pfizer Inc. and BioNTech SE asked the U.S. to authorize a new COVID-19 booster shot customized against the currently circulating COVID-19 variants as governments race to protect their populations against the ever-mutating virus.

In the U.S., officials have asked vaccine makers to target BA.5, rather than the original omicron strain. That has delayed the boosters' development — but officials hope they will be more effective.

The Government has confirmed who will get another Covid injection and says new vaccine will be used

Moderna's bivalent vaccine is seen as the "next step" in COVID protection.

Gritstone bio (NASDAQ:GRTS) announced that interim results from the Phase 1/2 trial of GRANITE, its individualized, vaccine-based immunotherapy candidate for solid tumor cancers, were published today in Nature Medicine. The initial results from the study are expected during second half of 2023. Gritstone shares traded in a range of $3.96 to $4.24…

The prime minister has made claims Australia must be more self-reliant.

The total number of COVID-19 cases identified in Australia since the start of the pandemic is closing in on 10 million.

An Omicron-specific booster vaccination has been approved in the UK